Your browser doesn't support javascript.
loading
Model-based assessment of combination therapies - ranking of radiosensitizing agents in oncology.
Baaz, Marcus; Cardilin, Tim; Lignet, Floriane; Zimmermann, Astrid; El Bawab, Samer; Gabrielsson, Johan; Jirstrand, Mats.
Afiliación
  • Baaz M; Fraunhofer-Chalmers Research Centre for Industrial Mathematics, Gothenburg, Sweden. Marcus.Baaz@fcc.chalmers.se.
  • Cardilin T; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden. Marcus.Baaz@fcc.chalmers.se.
  • Lignet F; Fraunhofer-Chalmers Research Centre for Industrial Mathematics, Gothenburg, Sweden.
  • Zimmermann A; Translational Medicine, Quantitative Pharmacology, Merck Healthcare KGaA, Darmstadt, Germany.
  • El Bawab S; Translation Innovation Platform Oncology, Merck Healthcare KGaA, Darmstadt, Germany.
  • Gabrielsson J; Translational Medicine, Quantitative Pharmacology, Merck Healthcare KGaA, Darmstadt, Germany.
  • Jirstrand M; Present Address: Translational Medicine, Servier, Suresnes, France.
BMC Cancer ; 23(1): 409, 2023 May 06.
Article en En | MEDLINE | ID: mdl-37149596
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Suecia